Is Alzheimer’s disease inevitable with age?
Open accessAbstract
The unprecedented and growing number of older adults in the US and other developed countries has crystallized scientific interest in the health consequences of aging.Perhaps the most feared of these consequences is Alzheimer's disease (AD).As the leading cause of dementia, AD not only extracts a terrible toll from patients and their families but is an enormous public health burden, with annual costs in the US alone approaching 100 billion dollars.The major risk factor for AD is living longer; AD prevalence doubles every 5 years after age 65 and approaches 50% by age 85 (1).Some epidemiologists report that the prevalence of AD continues to increase in the very old and conclude that "AD ... may become universal when age is sufficiently advanced" (2).As we enter the 21st century with increasing life expectancies, the obvious question becomes, "If we live long enough, will we all be demented?"(3).Although this question cannot be definitely resolved at present, accumulating evidence suggests that not all of us will.Before reviewing the data that led me to consider aging and AD as discrete rather than continuous processes, I should acknowledge 3 biases.First, I believe that for studies of cognitive aging, longitudinal study designs are preferable to cross-sectional designs, which may be confounded by cohort effects that overestimate
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies over the past 20 years have supported the existence of pre-clinical burden of pathology in AD.
“Studies over the past 20 years have supported the existence of pre-clinical burden of pathology in AD [99–101]”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [101]
Cites
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1× · see citing works
“NFTs appear in vulnerable brain regions as a function of age and are not associated with neuronal loss (16, 20).”
BackgroundSelf-citationEvans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226 · cited 2× · see citing works
“The major risk factor for AD is living longer; AD prevalence doubles every 5 years after age 65 and approaches 50% by age 85 (1).”
BackgroundAlzheimer neuropathologic alterations in aged cognitively normal subjects
Davis, D. G., Schmitt, F. A., Wekstein, D. R., & Markesbery, W. R. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00008 · Cited by 516 · cited 1× · see citing works
“Further investigations with larger numbers of nondemented control subjects revealed that AD may be present neuropathologically but was not associated with clinically detectable cognitive change during life (17, 18).”
BackgroundMorris, J. C., McKeel, D. W., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., Ball, M. J., & Berg, L. (1991) · Neurology · doi:10.1212/wnl.41.4.469 · Cited by 473 · see citing works
Self-citationNeurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370 · see citing works
HULETTE, C. M., WELSH-BOHMER, K. A., MURRAY, M. G., SAUNDERS, A. M., MASH, D. C., & MCINTYRE, L. M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00009 · Cited by 311 · see citing works
Haroutunian, V. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1185 · Cited by 289 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Head, D. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh003 · Cited by 645 · see citing works
Wang, L., Swank, J. S., Glick, I. E., Gado, M. H., Miller, M. I., Morris, J. C., & Csernansky, J. G. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00361-6 · Cited by 263 · see citing works
Self-citationThe Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features
Iverson, G. L., Keene, C. D., Perry, G., & Castellani, R. J. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170654 · Cited by 72 · see citing works
Pedersen, N. L., Posner, S. F., & Gatz, M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1608 · Cited by 55 · see citing works
- Authors
- Morris, J. C.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Morris, John C.
- ORCID
- Morris, John C.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-11-01
- Volume
- 104
- Issue
- 9
- Pages
- 1171-1173
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC409830
- OpenAlex
- W1538432629
- Cited by
- 56
- References
- 7
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2017: 1 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG03991, AG 05681, P50AG005681, P01AG003991)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Aging and Gerontology Research
- Keywords
- Alzheimer's disease, cognitive aging, dementia, aging, life expectancy, cohort effects, public health burden
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Cognition, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review